About This Project
BBRI and Los Angeles VA Medical Center
Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.
Browse Other Projects on Experiment
The aim of this project is to discover how Vespa Amino Acid Mixture (VAAM), a metabolic accelerant, impacts...
Where is this vulnerable Indian Ocean seabird feeding? Using micro-GPS to track seabirds in the Indian Ocean
Thankyou all! Please continue as it all helps! I have studied the Lesser Noddy at the Houtman Abrolhos, Western...